Supraphysiologic Testosterone Solutions for Enzalutamide-resistant Prostate Cancer

被引：5
|
作者：
Thomas, Lewis [1 ,2 ]
Baratchian, Mehdi [1 ]
Sharifi, Nima [1 ,2 ,3 ]
机构：
[1] Cleveland Clin, Lerner Res Inst, Genitourinary Malignancies Res Ctr, Cleveland, OH 44106 USA
[2] Cleveland Clin, Dept Urol, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Hematol & Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
EUROPEAN UROLOGY | 2020年 / 77卷 / 02期
关键词：
D O I：
10.1016/j.eururo.2019.07.037
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [31] Upregulation of glucocorticoid receptor-mediated glucose transporter 4 in enzalutamide-resistant prostate cancer
    Hoshi, Seiji
    Meguro, Satoru
    Imai, Hitomi
    Matsuoka, Yuta
    Yoshida, Yuki
    Onagi, Akihumi
    Tanji, Ryo
    Honda-Takinami, Ruriko
    Matsuoka, Kanako
    Koguchi, Tomoyuki
    Hata, Junya
    Sato, Yuichi
    Akaihata, Hidenori
    Kataoka, Masao
    Ogawa, Soichiro
    Kojima, Yoshiyuki
    CANCER SCIENCE, 2021, 112 (05) : 1899 - 1910
  • [32] A distinct epigenetic state sensitizes enzalutamide-resistant prostate cancer cells to BET bromodomain inhibition
    Shah, N.
    Arora, V. K.
    Karthaus, W.
    Wongvipat, J.
    Zheng, D.
    Sawyers, C.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S9 - S9
  • [33] Knockdown of EPS8 expression attenuates the proliferation of enzalutamide-resistant prostate cancer cells
    Huang, Wei-Lun
    Chen, Sih-Han
    Wu, Richard Chen-Yu
    Mai, Hsing-Cha
    Wu, Chun-Hsien
    Hsieh, Pei-Fang
    Pang, See-Tong
    Lin, Victor Chia-Hsiang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (10):
  • [34] Integrative transcriptional analysis of enzalutamide-resistant castration resistant prostate cancer cells using RNA sequencing.
    Kim, Tae Heon
    Kang, Minyong
    Oh, Ji Youn
    Kang, Yumi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [35] Aberrant tumor metabolism to enable glucocorticoid receptor takeover in enzalutamide-resistant prostate cancer.
    Sharifi, Nima
    Li, Jianneng
    Alyamani, Mohammad
    Zhang, Ao
    Chang, Kai-Hsiung
    Berk, Mike
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [36] Construction of enzalutamide-resistant cell model of prostate cancer and preliminary screening of potential drug-resistant genes
    Feng, Tao
    Wei, Dechao
    Zhao, Jiahui
    Li, Qiankun
    Guo, Pengju
    Yang, Xiaobing
    Li, Mingchuan
    Jiang, Yongguang
    Luo, Yong
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (15) : 1776 - 1787
  • [37] PlexinD1 drives enzalutamide-resistant neuroendocrine prostate cancer development and progression.
    Wang, Jing
    Li, Jingjing
    Wu, Boyang
    CANCER RESEARCH, 2021, 81 (13)
  • [38] Discovery of novel biphenyl derivatives as androgen receptor degraders for the treatment of enzalutamide-resistant prostate cancer
    Zhang, Wenqiang
    Fan, Yawen
    Zhang, Yan
    Feng, Yunrui
    Luo, Yi
    Zhou, Xiaoyu
    Chen, Zhuolin
    Wang, Chenxiao
    Lu, Tao
    Tang, Feng
    Chen, Yadong
    Li, Hongmei
    Jiao, Yu
    BIOORGANIC CHEMISTRY, 2024, 148
  • [39] Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants
    Banuelos, Carmen A.
    Ito, Yusuke
    Obst, Jon K.
    Mawji, Nasrin R.
    Wang, Jun
    Hirayama, Yukiyoshi
    Leung, Jacky K.
    Tam, Teresa
    Tien, Amy H.
    Andersen, Raymond J.
    Sadar, Marianne D.
    CANCERS, 2020, 12 (07) : 1 - 17
  • [40] THERAPEUTIC TARGETING OF TRANSCRIPTIONAL REPRESSOR BCL-6 IN ENZALUTAMIDE-RESISTANT CASTRATION-RESISTANT PROSTATE CANCER
    Hongo, Hiroshi
    Kosaka, Takeo
    Yasumizu, Yota
    Miyazaki, Yasumasa
    Kikuchi, Eiji
    Miyajima, Akira
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1173 - E1173
12345